SuperworthSELLAS Life Sciences shares outstanding SLS
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 189.2M
- On a year earlier
- +92.0%
- more shares
SELLAS Life Sciences had 189.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 92.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 140.9M | +91% |
| FY2024 | 73.9M | +140% |
| FY2023 | 30.8M | +48% |
| FY2022 | 20.8M | +31% |
| FY2021 | 15.9M | +53% |
| FY2020 | 10.4M | +116% |
| FY2019 | 4.8M | +1003% |
| FY2018 | 434.6K | +7949% |
| FY2015 | 5.4K | +30% |
| FY2014 | 4.1K | +17% |
| FY2013 | 3.6K | +53% |
| FY2012 | 2.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 189.2M | +92% | |
| Q1 FY26 | 172.5M | +97% | |
| Q4 FY25 | 140.9M | +91% | |
| Q3 FY25 | 108.4M | +59% | |
| Q2 FY25 | 98.6M | +71% | |
| Q1 FY25 | 87.8M | +96% | |
| Q4 FY24 | 73.9M | +140% | |
| Q3 FY24 | 68.3M | +141% | |
| Q2 FY24 | 57.6M | +103% | |
| Q1 FY24 | 44.8M | +90% | |
| Q4 FY23 | 30.8M | +48% | |
| Q3 FY23 | 28.4M | +38% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on SELLAS Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.